These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 32624882)

  • 21. A Review on Recent Technologies and Patents on Silica Nanoparticles for Cancer Treatment and Diagnosis.
    Gupta A; Kushwaha SS; Mishra A
    Recent Pat Drug Deliv Formul; 2020; 14(2):126-144. PubMed ID: 32928094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Facile Synthesis of Three Types of Mesoporous Silica Microspheres as Drug Delivery Carriers and their Sustained-Release Properties.
    Zhu Y; Wang B; Chen J; He J; Qiu X
    Curr Drug Deliv; 2023; 20(9):1337-1350. PubMed ID: 35713141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The void side of silica: surveying optical properties and applications of mesoporous silica.
    Olla C; Carbonaro CM
    J Phys Condens Matter; 2024 Mar; 36(25):. PubMed ID: 38545962
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in mesoporous silica nanoparticle-based targeted drug-delivery systems for cancer therapy.
    Li Y; Deng G; Hu X; Li C; Wang X; Zhu Q; Zheng K; Xiong W; Wu H
    Nanomedicine (Lond); 2022 Aug; 17(18):1253-1279. PubMed ID: 36250937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
    Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Mesoporous Nanoparticles for pH-Actuated Controlled Release.
    Gonçalves JLM; Crucho CIC; Alves SPC; Baleizão C; Farinha JPS
    Nanomaterials (Basel); 2019 Mar; 9(3):. PubMed ID: 30917559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Developments in Mesoporous Silica Nanoparticles for Tumor Theranostic Applications.
    Wang X; Zheng M; Raza F; Liu Y; Wei Y; Qiu M; Su J
    Curr Pharm Des; 2022; 28(2):151-164. PubMed ID: 34766889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.
    Mohamed Isa ED; Ahmad H; Abdul Rahman MB; Gill MR
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mesoporous silica nanomaterial-based biotechnological and biomedical delivery systems.
    Giri S; Trewyn BG; Lin VS
    Nanomedicine (Lond); 2007 Feb; 2(1):99-111. PubMed ID: 17716196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface Modification of Mesoporous Silica Nanoparticles for Application in Targeted Delivery Systems of Antitumour Drugs.
    Kovtareva S; Kusepova L; Tazhkenova G; Mashan T; Bazarbaeva K; Kopishev E
    Polymers (Basel); 2024 Apr; 16(8):. PubMed ID: 38675024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesoporous Silica Nanoparticles-Based Nanoplatforms: Basic Construction, Current State, and Emerging Applications in Anticancer Therapeutics.
    Feng Y; Liao Z; Li M; Zhang H; Li T; Qin X; Li S; Wu C; You F; Liao X; Cai L; Yang H; Liu Y
    Adv Healthc Mater; 2023 Jun; 12(16):e2201884. PubMed ID: 36529877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanocarriers for Biomedicine: From Lipid Formulations to Inorganic and Hybrid Nanoparticles.
    Kashapov R; Ibragimova A; Pavlov R; Gabdrakhmanov D; Kashapova N; Burilova E; Zakharova L; Sinyashin O
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209023
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multifunctional mesoporous silica nanoparticles as efficient transporters of doxorubicin and chlorin e6 for chemo-photodynamic combinatorial cancer therapy.
    Sun JH; Zhang W; Zhang DY; Shen J; Tan CP; Ji LN; Mao ZW
    J Biomater Appl; 2018 Apr; 32(9):1253-1264. PubMed ID: 29448866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Near-infrared light triggered drug release from mesoporous silica nanoparticles.
    Zhao T; Chen L; Li Q; Li X
    J Mater Chem B; 2018 Nov; 6(44):7112-7121. PubMed ID: 32254627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
    Tang F; Li L; Chen D
    Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesoporous silica nanoparticles: facile surface functionalization and versatile biomedical applications in oncology.
    Huang R; Shen YW; Guan YY; Jiang YX; Wu Y; Rahman K; Zhang LJ; Liu HJ; Luan X
    Acta Biomater; 2020 Oct; 116():1-15. PubMed ID: 32911102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy.
    Pan G; Jia TT; Huang QX; Qiu YY; Xu J; Yin PH; Liu T
    Colloids Surf B Biointerfaces; 2017 Nov; 159():375-385. PubMed ID: 28818782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesoporous silica nanoparticles in target drug delivery system: A review.
    Bharti C; Nagaich U; Pal AK; Gulati N
    Int J Pharm Investig; 2015; 5(3):124-33. PubMed ID: 26258053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.